International Journal of Biomedicine. 2022;12(4):622-626.
Originally published December 5, 2022
Background: Fast and accurate diagnosis plays an important role in controlling and further preventing COVID-19. This study was conducted in the Thumbay laboratory of Gulf Medical University (Ajman, UAE) to assess the correlations between DPI (Diffractive Phase Interferometry), COVID-19 RT-PCR, and CRP tests in COVID-19 patients of different ages and to compare the effectiveness of each parameter.
Methods and Results: A cross-sectional analytic study was conducted among 150 patients diagnosed with COVID-19 who were admitted to the Thumbay University Hospital. Their general data was collected from the LDM system, and from among the suspected patients who came to do the RT-PCR test, 230 were selected as volunteers to participate in this study, and further laboratory tests like CRP level and DPI test were done for them. The nasal swab was collected for a PCR test.
Out of 230 nasal swab samples, 150 were positive and 80 were negative for SARS-CoV-2 RNA by real-time RT-PCR assay. Among the 150 positive RT-PCR, 90 false negative DPI tests were from a sample with a high real-time RT-PCR. While 60 true positive DPI tests were positive real-time RT-PCR for swab specimens. Among the 80 negative RT-PCR, 79 were true negative and 1 was a false positive. The predictive positive value of the DPI test was 40% and the predictive negative value of the test was 98%. DPI has at least one tie between the positive actual state group and the negative actual state group. The results show weak and moderate positive correlations between CRP and the age groups.
Conclusion: The combined detection of the three indicators (RT-PCR, DPI, and CRP) are positively related to COVID-19 infection; therefore, these indicators will enable effective intervention measures to be implemented in time and the rates of severe illness and mortality to be reduced.
1. Taleghani N, Taghipour F. Diagnosis of COVID-19 for controlling the pandemic: A review of the state-of-the-art. Biosens Bioelectron. 2021 Feb 15; 174:112830. doi: 10.1016/j.bios.2020.112830. Epub 2020 Nov 27. PMID: 33339696; PMCID: PMC7694563
2. Al Hosany F, Ganesan S, Al Memari S, Al Mazrouei S, Ahamed F, Koshy A, Zaher W. Response to COVID-19 pandemic in the UAE: A public health perspective. J Glob Health. 2021 Mar 27; 11:03050. doi: 10.7189/jogh.11.03050. PMID: 33828834; PMCID: PMC8005306.
3. Borges LP, Martins AF, Silva BM, Dias BP, Gonçalves RL, Souza DRV, Oliveira MGB, Jesus PC, Serafini MR, Quintans JSS, Coutinho HDM, Martins N, Júnior LJQ. Rapid diagnosis of COVID-19 in the first year of the pandemic: A systematic review. Int Immunopharmacol. 2021 Dec;101(Pt A):108144. doi: 10.1016/j.intimp.2021.108144. Epub 2021 Sep 15. PMID: 34607235; PMCID: PMC8440261.
4. The United Arab Emirates' Government portal. Types of tests for detecting COVID-19 and testing for COVID-19. Available at: https://u.ae/en/information-and-services/justice-safety-and-the-law/hand...
5. MOHAP. COVID-19. Recent COVID-19 Information and Updates. Available at: https://mohap.gov.ae/en/covid-19
6. Ishige T, Murata S, Taniguchi T, Miyabe A, Kitamura K, Kawasaki K, Nishimura M, Igari H, Matsushita K. Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories. Clin Chim Acta. 2020 Aug;507:139-142. doi: 10.1016/j.cca.2020.04.023.
7. PureHealth. COVID-19: All You Need to Know About RT-PCR Tests and How They Can Be Conducted In The UAE Safely. Available at:
8. Al Harbi M, Al Kaabi N, Al Nuaimi A, Abdalla J, Khan T, Gasmelseed H, Khan A, Hamdoun O, Weber S. Clinical and laboratory characteristics of patients hospitalised with COVID-19: clinical outcomes in Abu Dhabi, United Arab Emirates. BMC Infect Dis. 2022 Feb 8;22(1):136. doi: 10.1186/s12879-022-07059-1. PMID: 35135491; PMCID: PMC8822868
9. Ramphul K, Mejias SG. Coronavirus Disease: A Review of a New Threat to Public Health. Cureus. 2020 Mar 15;12(3):e7276. doi: 10.7759/cureus.7276. PMID: 32300496; PMCID: PMC7158591.
10. Wang L. C-reactive protein levels in the early stage of COVID-19. Med Mal Infect. 2020 Jun;50(4):332-334. doi: 10.1016/j.medmal.2020.03.007. Epub 2020 Mar 31. PMID: 32243911; PMCID: PMC7146693.
11. Ahnach M, Zbiri S, Nejjari S, Ousti F, Elkettani C. C-reactive protein as an early predictor of COVID-19 severity. J Med Biochem. 2020 Oct 2;39(4):500-507. doi: 10.5937/jomb0-27554. PMID: 33312067; PMCID: PMC7710381.
12. Nayak S, Acharjya B. VDRL test and its interpretation. Indian J Dermatol. 2012 Jan;57(1):3-8. doi: 10.4103/0019-5154.92666. PMID: 22470199; PMCID: PMC3312652.
Received August 16, 2022.
Accepted September 17, 2022.
©2022 International Medical Research and Development Corporation.